Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Hangkang Pharmaceutical Co., Ltd., also known as Hacon, is a Chinese pharmaceutical company headquartered in Hangzhou, Zhejiang. Established in 1994, the company specializes in the development, manufacturing, and marketing of finished drug products (FDFs) across several therapeutic areas, including infectious diseases, metabolic disorders, and autoimmune conditions. Its product portfolio includes generic versions of linezolid, saxagliptin, and hydroxychloroquine sulfate, as well as specialized products like thrombin lyophilized powder and fibrin glue for surgical use. The company is also active in pediatric health, producing zinc gluconate granules for conditions such as rotavirus enteritis. Zhejiang Hangkang Pharmaceutical maintains a strong focus on bioequivalence studies to support its generic drug pipeline and operates manufacturing facilities that comply with national and international standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Hangkang Pharmaceutical.